Designs and manufactures wheelchairs and living aids for people with disabilities, older adults, and people recovering from injury.
20-F for FY2025, filed Feb 10, 2026The China-based VIE, Changzhou Zhongjin, and its subsidiaries, design and manufacture wheelchairs and living aids products for people with…View ↗
It mainly earns money from product sales to dealers, with sales counted when goods are delivered. Its Japanese distributor’s contract sets payment after shipment.
20-F for FY2025, filed Feb 10, 2026
FY2025 revenue by product or service ↗$20.7M
20-F for FY2025, filed Feb 10, 2026
$20.7M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Wheelchair
Sold outright
20-F for FY2025, filed Feb 10, 2026 |
78%
FY2022: 81%
|
Wheelchair, FY2025
$16.2M Sources
|
Sold outright |
|
Wheelchair components
Sold outright
|
9.1% |
Wheelchair components, FY2025
$1.9M Sources
|
Sold outright |
|
Other products
Sold outright
20-F for FY2025, filed Feb 10, 2026 |
12% |
Other products, FY2025
$2.6M Sources
|
Sold outright |
It mainly sells to qualified dealers, who distribute products to end users. Nissin is its sole Japanese distributor, while other dealers serve China and other regions.
20-F for FY2025, filed Feb 10, 2026
For the years ended September 30, 2025, 2024 and 2023, one customer accounted for approximately 58.6%, 47.6% and 69.8% of the Company’s…View ↗
Yes. It kept 6 cents of every revenue dollar as net income in FY2025, but spent more cash than it brought in: free cash flow was −$3.7M.
20-F for FY2025, filed Feb 10, 2026
$608.2KView ↗
20-F for FY2025, filed Feb 10, 2026
$1.2MView ↗
20-F for FY2025, filed Feb 10, 2026
−$3.7MView ↗
Flat. Revenue was $20.7M in FY2025, about the same as the $20.8M of FY2021.
Competes with Sangui Wheelchair Rehabilitation Equipment (Shanghai), Shanghai Jiekaiyang Medical Equipment, Matsunaga Welfare Appliance Manufacturing (Shanghai), and Jiangsu Yuyue Medical Equipment
20-F for FY2025, filed Feb 10, 2026Sangui Wheelchair Rehabilitation Equipment (Shanghai) Co. Ltd.View ↗
Loading...